Canada Pension Plan Investment Board
IOVA icon

Canada Pension Plan Investment Board’s Iovance Biotherapeutics IOVA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,800
Closed -$95.9K – 1212
2023
Q4 		$95.9K Hold
11,800
– – ﹤0.01% 1045
2023
Q3 		$53.7K Hold
11,800
– – ﹤0.01% 965
2023
Q2 		$83.1K Hold
11,800
– – ﹤0.01% 960
2023
Q1 		$72.1K Hold
11,800
– – ﹤0.01% 1005
2022
Q4 		$75.4K Hold
11,800
– – ﹤0.01% 1051
2022
Q3 		$113K Sell
11,800
-3,000
-20% -$34.6K ﹤0.01% 1072
2022
Q2 		$164K Buy
14,800
+3,900
+36% +$51.1K ﹤0.01% 1099
2022
Q1 		$181K Buy
+10,900
New +$169K ﹤0.01% 1116

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Canada Pension Plan Investment Board's IOVA Position: Q1 2024 in Review

Canada Pension Plan Investment Board sold out of Iovance Biotherapeutics (IOVA) in Q1 2024, closing a stake of 11,800 shares — an estimated $95.9K sold.

Canada Pension Plan Investment Board first reported a position in IOVA in Q1 2022 and held it in 8 quarters. The position peaked at $181K in Q1 2022. 273 funds tracked by Wall St. Rank hold IOVA as of Q1 2024.

  • Canada Pension Plan Investment Board reported no remaining Iovance Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 11,800 Iovance Biotherapeutics shares in Q1 2024, an estimated $95.9K.
  • Canada Pension Plan Investment Board first reported a position in Iovance Biotherapeutics in Q1 2022 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Iovance Biotherapeutics position peaked at $181K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2024, filed 14 May 2024.